Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.21.2
Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Common Shares Issuable [Member]
Treasury Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Total
Balance at Dec. 31, 2019 $ 1 $ 74 $ 500   $ 461,874 $ (436,234) $ 46,317 $ 72,532
Balance (in shares) at Dec. 31, 2019 1,341,167 74,027,425            
Stock-based compensation expense         10,319     10,319
Issuance of common stock related to equity plans   $ 2     (2)      
Issuance of common stock related to equity plans (in shares)   2,307,231            
Issuance of common stock under ESPP         90     90
Issuance of common stock under ESPP (in shares)   53,268            
Preferred A dividends declared and paid         (4,507)     (4,507)
Partner company's at-the-market offering, net         33,500     33,500
Issuance of common stock for at-the-market offering, net   $ 17     43,183     43,200
Issuance of common stock for at-the-market offering, net (in shares)   16,378,234            
Repurchase of Series A preferred stock, net       $ (70) (2)     (72)
Repurchase of Series A preferred stock (in shares) (5,000)              
Retirement of Series A preferred stock       $ 70 (70)      
Issuance of Series A preferred stock for cash, net $ 2       35,466     35,468
Issuance of Series A preferred stock for cash, net (in shares) 2,090,971.0              
Partner company's offering, net         53,698     53,698
Partner company's preferred stock offering, net         7,088     7,088
Partner company's dividends declared and paid         (50)     (50)
Partner company's exercise of warrants for cash         13     13
Reclass partner company's warrants from liability to equity         1,216     1,216
Partner company's ESPP         349     349
Issuance of partner company's common shares for research and development expenses         42     42
Common shares issued for 2017 Subordinated Note Financing interest expense   $ 1 (500)   1,816     1,317
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   982,216            
Common shares issuable for 2017 Subordinated Note Financing interest expense     18         18
Common shares issued for dividend on partner company's convertible preferred shares               0
Common shares issuable for 2019 Notes interest expense         4,419     4,419
Non-controlling interest in subsidiaries/partner companies         (73,981)   73,981  
Net loss attributable to non-controlling interest             (41,264) (41,264)
Net loss attributable to common stockholders           (41,231)   (41,231)
Balance at Sep. 30, 2020 $ 3 $ 94 18   574,461 (477,465) 79,034 176,145
Balance (in shares) at Sep. 30, 2020 3,427,138 93,748,374            
Balance at Jun. 30, 2020 $ 3 $ 86 813   521,493 (461,918) 56,381 116,858
Balance (in shares) at Jun. 30, 2020 2,693,806 86,113,331            
Stock-based compensation expense         3,171     3,171
Issuance of common stock related to equity plans (in shares)   268,800            
Preferred A dividends declared and paid         (1,719)     (1,719)
Partner company's at-the-market offering, net         23,053     23,053
Issuance of common stock for at-the-market offering, net   $ 7     21,110     21,117
Issuance of common stock for at-the-market offering, net (in shares)   7,064,214            
Issuance of Series A preferred stock for cash, net         11,965     11,965
Issuance of Series A preferred stock for cash, net (in shares) 733,332              
Partner company's offering, net         18,774     18,774
Issuance of common stock under partner company's ESPP         180     180
Partner company's preferred stock offering, net         7,088     7,088
Partner company's dividends declared and paid         (50)     (50)
Reclass partner company's warrants from liability to equity         1,216     1,216
Issuance of partner company's common shares for research and development expenses         21     21
Common shares issued for 2017 Subordinated Note Financing interest expense   $ 1 (500)   810     311
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   302,029            
Write off common shares issuable for 2019 Notes interest expense     (313)         (313)
Common shares issuable for service     18         18
Issuance of warrants in conjunction with Oaktree Note         4,419     4,419
Non-controlling interest in subsidiaries/partner companies         (37,070)   37,070  
Net loss attributable to non-controlling interest             (14,417) (14,417)
Net loss attributable to common stockholders           (15,547)   (15,547)
Balance at Sep. 30, 2020 $ 3 $ 94 18   574,461 (477,465) 79,034 176,145
Balance (in shares) at Sep. 30, 2020 3,427,138 93,748,374            
Balance at Dec. 31, 2020 $ 3 $ 95     583,000 (482,760) 96,661 196,999
Balance (in shares) at Dec. 31, 2020 3,427,138 94,877,492            
Stock-based compensation expense         12,449     12,449
Issuance of common stock related to equity plans   $ 3     (3)      
Issuance of common stock related to equity plans (in shares)   2,912,652            
Issuance of common stock under ESPP         137     137
Issuance of common stock under ESPP (in shares)   59,107            
Preferred A dividends declared and paid         (6,023)     (6,023)
Partner company's at-the-market offering, net         101,958     101,958
Partner company's exercise of options for cash         7     7
Issuance of common stock for at-the-market offering, net   $ 1     2,747     2,748
Issuance of common stock for at-the-market offering, net (in shares)   786,300            
Issuance of common stock under partner company's ESPP         309     309
Partner company's dividends declared and paid         (562)     (562)
Issuance of partner company's common shares for research and development expenses         136     136
Common shares issued for dividend on partner company's convertible preferred shares         263     263
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   78,671            
Common shares issuable for dividend on partner company's convertible preferred shares     365         365
Non-controlling interest in subsidiaries/partner companies         (86,329)   86,329  
Net loss attributable to non-controlling interest             (63,180) (63,180)
Net loss attributable to common stockholders           (33,138)   (33,138)
Balance at Sep. 30, 2021 $ 3 $ 99 365   608,089 (515,898) 119,810 212,468
Balance (in shares) at Sep. 30, 2021 3,427,138 98,714,222            
Balance at Jun. 30, 2021 $ 3 $ 97 263   603,035 (495,117) 140,020 248,301
Balance (in shares) at Jun. 30, 2021 3,427,138 97,495,244            
Stock-based compensation expense         4,326     4,326
Issuance of common stock related to equity plans   $ 1     (1)      
Issuance of common stock related to equity plans (in shares)   354,007            
Preferred A dividends declared and paid         (2,008)     (2,008)
Partner company's at-the-market offering, net         4,626     4,626
Issuance of common stock for at-the-market offering, net   $ 1     2,747     2,748
Issuance of common stock for at-the-market offering, net (in shares)   786,300            
Issuance of common stock under partner company's ESPP         151     151
Partner company's dividends declared and paid         (187)     (187)
Issuance of partner companies' common shares for research and development expenses         7     7
Common shares issued for dividend on partner company's convertible preferred shares     (263)   263      
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   78,671            
Common shares issuable for dividend on partner company's convertible preferred shares     365         365
Non-controlling interest in subsidiaries/partner companies         (4,870)   4,870  
Net loss attributable to non-controlling interest             (25,080) (25,080)
Net loss attributable to common stockholders           (20,781)   (20,781)
Balance at Sep. 30, 2021 $ 3 $ 99 $ 365   $ 608,089 $ (515,898) $ 119,810 $ 212,468
Balance (in shares) at Sep. 30, 2021 3,427,138 98,714,222